Tokyo, Japan and Cambridge, UK, 8August 2025 – Nxera Pharma (“the Company” or “Nxera”; TSE: 4565) provides an update on operational activities and reports its consolidated results for the second quarter…Read More

You might also be interested in reading BIS chief warns U.S. dollar stablecoins could destabilize global markets.